Simple Summary The prognosis and treatment of metastatic melanoma have changed
substantially since the advent of target therapy and immune checkpoint inhibitors. Thus …

Simple Summary Cutaneous Melanoma is a form of skin cancer characterized by an
elevated mutational load that favors high spread to distant organs and resistance to …

Earlier identification of aggressive melanoma remains a goal in the field of melanoma
research. With new targeted and immune therapies that have revolutionized the care of …

The incidence of cutaneous melanoma has more than doubled over the last decades
making it one of the fastest rising cancers worldwide. Improved awareness and early …

Malignant melanoma is one of the most common cancers in the world. In the disease's early
stages, treatment involves surgery, in advanced stages however, treatment options were …

Melanoma is an aggressive form of skin cancer characterized by poor prognosis and high
mortality. The development of targeted agents based on the discovery of driver mutations as …

Introduction Over the past decade, significant advancements in the field of melanoma have
included the introduction of a new staging system and the development of immunotherapy …

Melanoma is the most deadly skin cancer. The incidence and mortality rates of this tumor
have been increasing over the last number of decades. Besides clinical and …

Skin melanoma, a life-threatening disease, has a recently reported worldwide increase in
incidence, despite primary prevention. Skin melanoma statistics emphasize the need for …

In an era of personalized medicine, disease specific biomarkers play an increasing role in
the stratification of high-risk patient groups. Cutaneous malignant melanoma is the most …